Xinjiang Bai Hua Cun Pharma Tech Co.,ltd
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Xinjiang Baihuacun Pharmaceutical Group Co., Ltd. was founded in 1959 and listed on the Shanghai Stock Exchange in 1996 with stock code 600721. Its registered address is in Wujiaqu City, Xinjiang. Mainly engaged in pharmaceutical research and development, clinical trials, testing and analysis, commercial property management, and other businesses. Including Huawei Pharmaceutical, which focuses on pharmaceutical research and development, Lihua Biotechnology, which focuses on clinical trials, Liwei Biotechnology, which focuses on innovative technology platforms, Ximosbo, which focuses on analysis and testing business, and commercial property management, a total of 12 subsidiaries. The company has a commercial complex building of 46000 square meters in Urumqi and two office research and development buildings of approximately 30000 square meters in Nanjing. We have well-established internationally advanced pharmaceutical research instruments and equipment as well as a research and development management system, and have established multiple clinical research centers in major cities across the country. The technical backbone and R&D management team, with multiple doctoral and master's degrees as the core, are committed to the development of small molecule chemical raw materials and high-end formulations, drug quality research, clinical research, analysis and testing, as well as R&D registration and application. They have achieved remarkable research results and have obtained more than 100 Chinese and international PCT technology invention patents. In China, they have registered and obtained more than 300 clinical approvals, new drug certificates, and production approvals. The company has become a leading pharmaceutical research and development outsourcing service provider in the same industry in China, providing partners with one-stop full process services for the development of new and generic drugs. |
| Headquarter | Wujiaqu City |
| Establish Date | 6/21/1996 |
| Listed Code | 600721.SH |
| Listed Date | 6/26/1996 |
| Chairman | Zheng Caihong. |
| CEO | |
| Website | www.xjbhc.net |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
